Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma, Myeloma & Leukemia|October 5, 2015
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms GroupShireen Sirhan, Lambert Busque, Lynda Foltz, et al.
Therapeutic Advances in Hematology|July 7, 2025
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch studySteffen Koschmieder, Clemens Schulte, Eyck von der Heyde, et al.
Blood Advances|June 4, 2020
High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potentialLambert Busque, Maxine Sun, Manuel Buscarlet, et al.
Blood Advances|January 7, 2026
MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasmsMarie Ouellet, Angelo Rizzolo, Caroline Venne, et al.
European Journal of Haematology|August 5, 2020
Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donorsJean-Sébastien Claveau, Sandra Cohen, Imran Ahmad, et al.
Cancer|November 14, 2018
Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemiaAdi J Klil-Drori, Hui Yin, Laurent Azoulay, et al.
Plos Medicine|March 24, 2007
Prediction of graft-versus-host disease in humans by donor gene-expression profilingChantal Baron, Roland Somogyi, Larry D Greller, et al.
Ophthalmic Genetics|September 26, 2017
Identification of the genetic determinants responsible for retinal degeneration in families of Mexican descentAdda Villanueva, Pooja Biswas, Kameron Kishaba, et al.
British Journal of Haematology|May 29, 2019
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxisDenis Claude Roy, Sylvie Lachance, Sandra Cohen, et al.
Leukemia Research|September 1, 2023
Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapyFatima M Khadadah, Sonia Cerquozzi, Harold J Olney, et al.
Pageof 8